Yi Lin, MD, PhD | oneAMYLOIDOSISvoice
Healthcare Professionals

Yi Lin, MD, PhD

Healthcare Professional
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Yi Lin is a Hematologist and Chair at Cell Therapy Group, Division of Hematology, Mayo Clinic, Rochester, Minnesota. She completed her graduation and PhD from University of Minnesota and MD from Northwestern University Feinberg School of Medicine. Dr. Yi Lin completed Residency in Internal Medicine and a obtained Fellowship in Hematology and Medical Oncology from Mayo Clinic College of Medicine. 

Dr. Yi Lin has special interests in cellular therapy, cancer vaccine, immunotherapy, myeloid cell biology, myeloma, dysproteinemia, amyloidosis and lymphoma.  

Representative Publications:

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio 

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.